AI-Based Image Reconstruction Solution Receives FDA Clearance
By MedImaging International staff writers Posted on 06 Jul 2019 |
Image: A comparison between CT images reconstructed using standard iterative reconstruction software and Canon\'s AiCE solution (Photo courtesy of Canon Medical).
Canon Medical Systems USA, Inc. (Tustin, CA, USA) has received 510(k) clearance from the FDA for its new deep convolutional neural network (DCNN) image reconstruction technology. Canon Medical’s Advanced Intelligent Clear-IQ Engine (AiCE) uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal.
The algorithm has the ability to learn from the high image quality of Model Based Iterative Reconstruction (MBIR) to reconstruct CT images with improved spatial resolution, 3-5x times faster than traditional MBIR. With AiCE’s deep learning approach, thousands of features learned during training help to differentiate signal from noise for improved resolution. AiCE applies a pre-trained DCNN to enhance spatial resolution while simultaneously reducing noise with reconstruction speeds fast enough for busy clinical environments.
“Our AiCE technology utilizes a next generation approach to CT image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Canon Medical Systems USA. “This technology doesn’t just meet our customers’ evolving needs, it exceeds them, opening doors to clearer, more precise images to help optimize patient care.”
The algorithm has the ability to learn from the high image quality of Model Based Iterative Reconstruction (MBIR) to reconstruct CT images with improved spatial resolution, 3-5x times faster than traditional MBIR. With AiCE’s deep learning approach, thousands of features learned during training help to differentiate signal from noise for improved resolution. AiCE applies a pre-trained DCNN to enhance spatial resolution while simultaneously reducing noise with reconstruction speeds fast enough for busy clinical environments.
“Our AiCE technology utilizes a next generation approach to CT image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Canon Medical Systems USA. “This technology doesn’t just meet our customers’ evolving needs, it exceeds them, opening doors to clearer, more precise images to help optimize patient care.”
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases